España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Pfizer
PFE
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$28.30
-0.22
-0.77%
At close: -
$28.34
0.04
0.14%
After Hours: 6:53 PM EDT
15 minutes delayed
Get Report
Comment
The dividend Ex-Date is in 8 days
Q3 2024 Earnings were released on Tue Oct 29th, before the market open
The most recent conference call was at 10:30 AM, 2 days ago
Click to view past webcast
Pfizer (PFE) Forecast
News
Earnings
Pfizer (PFE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Pfizer (NYSE:PFE) Stock
Pfizer Stock (NYSE: PFE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, October 30, 2024
Reported Earlier, 'Novo Nordisk's Ozempic and...
Benzinga Newsdesk
CNBC Halftime Report Final Trades: Dell Techn...
Benzinga Newsdesk
Nasdaq Hits Record High Ahead Of Big Tech Earnings: Fear Index Remains In 'Greed' Zone
Avi Kapoor
Tuesday, October 29, 2024
Tech Stocks Rise Ahead Of Key Earnings, Gold Smashes Records, Bitcoin Nears All-Time Highs: What's Driving Markets Tuesday?
Piero Cingari
Pfizer CEO Says Will Do 'Whatever It Takes' T...
Benzinga Newsdesk
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
Avi Kapoor
Pfizer CEO Bourla Says Meeting With Starboard...
Benzinga Newsdesk
Pfizer Q3 Earnings: Revenue And Profit Beat On Heightened Demand For Paxlovid, Expects $10 Billion In 2024 Revenue From COVID Products
Vandana Singh
US Stocks Likely To Open Weaker As Investors Eye Alphabet, AMD And Pfizer Earnings: Expert Says Won't Be 'Surprised' If Earnings Exceed Wall Street Expectations
Rounak Jain
Pfizer shares are trading higher after the co...
Benzinga Newsdesk
Pfizer Expects 2024 Sales Of $61B-$64B Compar...
Benzinga Newsdesk
Pfizer Expects 2024 Adjusted EPS Of $2.75-$2....
Benzinga Newsdesk
Pfizer Q3 2024 Adj. EPS $1.06 Beats $0.62 Est...
Benzinga Newsdesk
Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
Avi Kapoor
Pfizer, Alphabet And 3 Stocks To Watch Heading Into Tuesday
Avi Kapoor
Monday, October 28, 2024
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
Juan Spínelli
Google To Launch New "Sexual Health & Wellnes...
Benzinga Newsdesk
Friday, October 25, 2024
Cantor Fitzgerald Reiterates Overweight on Pf...
Benzinga Newsdesk
Pfizer Option Alert: Jan 17 $37.5 Calls Sweep...
Benzinga Newsdesk
Pfizer, Live Nation Entertainment And More On CNBC's 'Final Trades'
Avi Kapoor
Thursday, October 24, 2024
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
Vandana Singh
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
Vandana Singh
CNBC Halftime Report Final Trades: Pfizer, Li...
Benzinga Newsdesk
Wednesday, October 23, 2024
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
Vandana Singh
Pfizer Says CDC's Advisory Committee On Immun...
Benzinga Newsdesk
Key Takeaways From Pfizer Analyst Ratings
Benzinga Insights
A Closer Look at Pfizer's Options Market Dynamics
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Pf...
Benzinga Newsdesk
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
Vandana Singh
Tuesday, October 22, 2024
Pfizer Says FDA Approved RSV Vaccine ABRYSVO ...
Benzinga Newsdesk
Activist Investor Starboard Slams Pfizer for Underperforming R&D And Overpaying for Acquisitions
Vandana Singh
Pfizer Earnings Expected To Grow: What to Know Ahead Of Next Week's Release
Zacks
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
Surbhi Jain
Starboard CEO Jeff Smith Says Something Mater...
Benzinga Newsdesk
Starboard CEO Jeff Smith Says Consensus Estim...
Benzinga Newsdesk
Starboard CEO Jeff Smith Says Return On Inves...
Benzinga Newsdesk
Starboard Value Says Pfizer Appears To Have O...
Benzinga Newsdesk
Thursday, October 17, 2024
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Vandana Singh
Bernstein Initiates Coverage On Pfizer with M...
Benzinga Newsdesk
Wednesday, October 16, 2024
Guggenheim's Longstanding Pfizer Ties Tested Amid Starboard Battle
Vandana Singh
ViiV Healthcare, Owned By GSK, Pfizer And Shi...
Benzinga Newsdesk
Tuesday, October 15, 2024
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
Vandana Singh
Monday, October 14, 2024
These 3 Stocks Just Spiked—Buy the Rally or Sell the News?
MarketBeat
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
Vandana Singh
Friday, October 11, 2024
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Vandana Singh
U.S. FDA Approves Pfizer's HYMPAVZI For The T...
Benzinga Newsdesk
(PFE) - Analyzing Pfizer's Short Interest
Benzinga Insights
Thursday, October 10, 2024
GSK and Pfizer shares are trading lower amid ...
Benzinga Newsdesk
GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations
Vandana Singh
Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer
Upwallstreet
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch